19 December 2019 - Deborah Wilkes
Archived
Hypera Pharma is acquiring the Buscopan and Buscofem brands in its home market of Brazil from Boehringer Ingelheim for BRL1.30 billion (USD0.32 billion).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.